Literature DB >> 11795103

Morbidity and mortality following abdominoperineal resection for low rectal adenocarcinoma.

P Luna-Pérez1, S Rodríguez-Ramírez, J Vega, E Sandoval, S Labastida.   

Abstract

BACKGROUND: Abdominoperineal resection (APR) has been the standard treatment of low rectal cancer, but it is associated with significant morbidity and mortality. AIM: To analyze the morbidity and mortality rates associated with this surgical procedure performed at a tertiary-level cancer center.
MATERIALS AND METHODS: From 1995-1999, 137 patients with rectal cancer located between 0 and 8 cm from the anal verge underwent APR. Covariates were analyzed mean chi 2 and those favorable or adverse covariates affecting the perineal infection and recurrences were analyzed by logistic regression analysis.
RESULTS: There were 78 males and 59 females, with a mean age of 57.4 +/- 14.6 years. Mean intraoperative hemorrhage was 739 +/- 547 mL; 51 (37.2%) patients received blood transfusion. Seventy-two patients received preoperative radiotherapy (PRT): 22, postoperative chemo-radiation therapy; 21, PRT + chemotherapy, and 22, APR only. Seventeen patients (12.4%) had major complications and 47 (34.3%) had minor complications. Twenty patients (14.6%) developed perineal wound infection. The main factors influencing these complications were administration of PRT +/- chemotherapy and age over 55 years. Operative mortality was 0.7%. Median follow-up was 32 months. Twelve patients (8.8%) had local recurrence and 35 (25.7%) had distant recurrence. Overall five-year survival was 75%.
CONCLUSIONS: APR is a surgical procedure associated with significant morbidity but low postoperative surgical mortality. The main cause of morbidity was perineal would infection influenced by administration of PRT +/- chemotherapy and age over 55 years. However, this treatment association is linked with low rate of local recurrence.

Entities:  

Mesh:

Year:  2001        PMID: 11795103

Source DB:  PubMed          Journal:  Rev Invest Clin        ISSN: 0034-8376            Impact factor:   1.451


  25 in total

1.  Complications of perineal surgery.

Authors:  James W Ogilvie; Rocco Ricciardi
Journal:  Clin Colon Rectal Surg       Date:  2009-02

2.  Implementing a standard protocol to decrease the incidence of surgical site infections in rectal cancer surgery.

Authors:  Minako Kobayashi; Yasuhiro Inoue; Yasuhiko Mohri; Chikao Miki; Masato Kusunoki
Journal:  Surg Today       Date:  2010-03-26       Impact factor: 2.549

3.  A phase II trial of neoadjuvant chemoradiation and local excision for T2N0 rectal cancer: preliminary results of the ACOSOG Z6041 trial.

Authors:  Julio Garcia-Aguilar; Qian Shi; Charles R Thomas; Emily Chan; Peter Cataldo; Jorge Marcet; David Medich; Alessio Pigazzi; Samuel Oommen; Mitchell C Posner
Journal:  Ann Surg Oncol       Date:  2011-07-14       Impact factor: 5.344

Review 4.  Adaptive radiation dose escalation in rectal adenocarcinoma: a review.

Authors:  Jonathan D Van Wickle; Eric S Paulson; Jerome C Landry; Beth A Erickson; William A Hall
Journal:  J Gastrointest Oncol       Date:  2017-10

5.  Wound dehiscence after abdominoperineal resection for low rectal cancer is associated with decreased survival.

Authors:  Alexander T Hawkins; David L Berger; Paul C Shellito; Patrica Sylla; Liliana Bordeianou
Journal:  Dis Colon Rectum       Date:  2014-02       Impact factor: 4.585

6.  Local excision carcinoma in early stage.

Authors:  Ji-Dong Gao; Yong-Fu Shao; Jian-Jun Bi; Su-Sheng Shi; Jun Liang; Yu-Hua Hu
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

7.  Surveillance after neoadjuvant therapy in advanced rectal cancer with complete clinical response can have comparable outcomes to total mesorectal excision.

Authors:  Radhika K Smith; Robert D Fry; Najjia N Mahmoud; E Carter Paulson
Journal:  Int J Colorectal Dis       Date:  2015-03-19       Impact factor: 2.571

8.  Neoadjuvant radiation therapy prior to total mesorectal excision for rectal cancer is not associated with postoperative complications using current techniques.

Authors:  Sarah A Milgrom; Karyn A Goodman; Garrett M Nash; Philip B Paty; José G Guillem; Larissa K Temple; Martin R Weiser; Julio Garcia-Aguilar
Journal:  Ann Surg Oncol       Date:  2014-03-07       Impact factor: 5.344

9.  Early and late complications among long-term colorectal cancer survivors with ostomy or anastomosis.

Authors:  Liyan Liu; Lisa J Herrinton; Mark C Hornbrook; Christopher S Wendel; Marcia Grant; Robert S Krouse
Journal:  Dis Colon Rectum       Date:  2010-02       Impact factor: 4.585

10.  Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results.

Authors:  Angelita Habr-Gama; Rodrigo Oliva Perez; Wladimir Nadalin; Jorge Sabbaga; Ulysses Ribeiro; Afonso Henrique Silva e Sousa; Fábio Guilherme Campos; Desidério Roberto Kiss; Joaquim Gama-Rodrigues
Journal:  Ann Surg       Date:  2004-10       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.